Application 206314
- Type
- ANDA
- Sponsor
- TARO
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | FELBAMATE | FELBAMATE | SUSPENSION;ORAL | 600MG/5ML | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0121-0891 | Felbamate | Felbamate | Pharmaceutical Associates, Inc. | ANDA | Current |
| 16714-775 | Felbamate | Felbamate | NORTHSTAR RX LLC | ANDA | Current |
| 51672-4172 | Felbamate | Felbamate | Taro Pharmaceuticals U.S.A., Inc. | ANDA | Current |